2021
DOI: 10.1007/s11239-021-02593-2
|View full text |Cite
|
Sign up to set email alerts
|

A comprehensive review of vascular complications in COVID-19

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
20
0
2

Year Published

2022
2022
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(22 citation statements)
references
References 88 publications
(109 reference statements)
0
20
0
2
Order By: Relevance
“…COVID-19 is associated with vascular complications including increased risk of micro-and macrovascular thromboembolism [39]. Several alterations in the coagulation pathway promoting a hypercoagulable state have been linked to COVID-19-associated coagulopathy [40]. In the abdomen, findings of bowel ischemia due to mesenteric and portal vein thrombosis, arterial mesenteric thrombosis and arterial dissections of the splanchnic vessels have been described [41][42][43][44].…”
Section: Discussionmentioning
confidence: 99%
“…COVID-19 is associated with vascular complications including increased risk of micro-and macrovascular thromboembolism [39]. Several alterations in the coagulation pathway promoting a hypercoagulable state have been linked to COVID-19-associated coagulopathy [40]. In the abdomen, findings of bowel ischemia due to mesenteric and portal vein thrombosis, arterial mesenteric thrombosis and arterial dissections of the splanchnic vessels have been described [41][42][43][44].…”
Section: Discussionmentioning
confidence: 99%
“…In light of the current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for the scope of this review it is important to mention vascular complications that are linked to TLRs immune response ( 173 ). SARS-CoV-2 induces release of proinflammatory cytokines and activation of procoagulant factors that activate coagulation cascades leading to thrombosis, rupture of atherosclerotic plaques and ischemic events ( 174 , 175 ).…”
Section: Sars-cov-2 and Tlr Signalingmentioning
confidence: 99%
“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes an aggressive infection with potentially serious health consequences, coronavirus disease 2019 (COVID-19). Although COVID-19 primarily causes respiratory infection, recent studies have shifted their attention to vascular complications of this disease, including alarming thromboembolism [1]. This case series underscores the importance of recognizing hypercoagulability as a cause of arterial thrombus presenting as bowel ischemia and blue toe syndrome in patients with COVID-19.…”
Section: Introductionmentioning
confidence: 82%
“…Inflammatory cytokine release mediates atherosclerosis and results in hemodynamic changes because of the induction of procoagulant mediators. It is believed that a storm of inflammatory mediators such as cytokines triggered by SARS-CoV-2 results in irreversible multisystem inflammation that can partially present as abnormal hemostasis and coagulopathy, further aggravating organ injury [1].…”
Section: Discussionmentioning
confidence: 99%